ライフサイエンスコーパス: HIFU

1 HIFU ablation was performed in one session with US guida

2 HIFU also increased the uptake of the antibody in surrou

3 HIFU combined with TACE is a safe and promising method w

4 HIFU is a non-invasive and highly effective standard tre

5 HIFU is a non-invasive approach that uses a precisely de

6 HIFU is often used for ablative therapies and must be ad

7 HIFU provides an excellent option to treat uterine fibro

8 HIFU treatment for localized PC can be considered as an

9 HIFU-induced bubbles provide an alternative means to des

10 h a diagnostic ultrasound machine during 180 HIFU exposures of five freshly excised, degassed bovine

11 Compared with traditional ablative HIFU, nondestructive pulsed HIFU (pHIFU) is present in t

12 Across HIFU exposure amplitude ranges, passive acoustic mapping

13 Studies addressing HIFU in leiomyomas were identified from a search of the

14 MATERIAL/METHODS: Studies addressing HIFU in localized PC were identified in a search of inte

15 ient was found to have lung metastasis after HIFU and had an operation to remove the lesion.

16 All HIFU heating strategies combined with TSLs resulted in c

17 ecent years, improvements in cryotherapy and HIFU have increased efficacy whereas decreasing complica

18 ble of simultaneous fluorescence mapping and HIFU ablation.

19 However, MB and HIFU are limited by the half-life of the contrast agent

20 ll patients received chemotherapy, TACE, and HIFU ablation.

21 f whole-heart (n=6) preparations by applying HIFU at clinical doses (4-16 W).

22 l hyperecho technique as an ultrasound-based HIFU monitoring method, as both a detector of lesion occ

23 used to assess functional damage produced by HIFU.

24 n bulk tissues in large animals and clinical HIFU system revealed correlation between therapeutic eff

25 on the same bulk tissues although different HIFU systems were used.

26 isplacement of 1 to 3 mm was observed during HIFU application due to acoustic radiation force along t

27 lease following short duration ( 20min each) HIFU treatments administered sequentially over an hour i

28 lease following short duration (~20min each) HIFU treatments administered sequentially over an hour i

29 nance imaging enables accurate targeting for HIFU as well as temperature monitoring during treatment.

30 acoustic pressure and high temperature from HIFU generated cavitation, causing macroscopic tissue da

31 his work a magnetic resonance imaging guided HIFU (MRgHIFU) controlled feedback system was developed

32 MR imaging-guided HIFU ablation of bone may result in progressive remodeli

33 maging 3 and 6 weeks after MR imaging-guided HIFU ablation were similar between proximal (low-energy)

34 itor bone remodeling after MR imaging-guided HIFU ablation.

35 ents who were treated with MR imaging-guided HIFU only.

36 idence of the potential of MR imaging-guided HIFU to be part of a routine strategy for the treatment

37 MR imaging-guided HIFU was used to create distal and proximal ablations in

38 clinical effectiveness of MR imaging-guided HIFU were considered primary outcomes; tumor control at

39 cal efficacy and safety of MR imaging-guided HIFU were demonstrated.

40 nd no contraindications to MR imaging-guided HIFU were enrolled between June 2010 and June 2013.

41 cruited patients underwent MR imaging-guided HIFU.

42 Early data suggest that US-guided HIFU ablation is an effective and safe procedure for tre

43 In HIFU, ultrasound energy from an extracorporeal source is

44 progressed, the delivery of Dox decreased in HIFU-treated tumors with ELTSLs, but this phenomenon was

45 hod exhibits a great potential for measuring HIFU field under high-pressure amplitude.

46 Most HIFU therapies are designed to use heating effects resul

47 ees C) was applied to the tumors using an MR-HIFU system.

48 and injected in tumor-bearing rats before MR-HIFU treatment.

49 ted outcome and patient management during MR-HIFU procedure.

50 For the LTSL + MR-HIFU group, mild hyperthermia (40-41 degrees C) was appl

51 LTSL + MR-HIFU resulted in significantly higher tumor doxorubicin

52 In contrast, LTSL + MR-HIFU treatment suggested an improved distribution with d

53 ) free doxorubicin, 2) LTSL and 3) LTSL + MR-HIFU.

54 guided High-Intensity Focused Ultrasound (MR-HIFU) is a noninvasive technique for ablation therapy fo

55 guided high intensity focused ultrasound (MR-HIFU) platform to investigate in vivo image-guided drug

56 guided high-intensity focused ultrasound (MR-HIFU) was used as a noninvasive heating device with prec

57 on, hyperthermia followed by ablation, or no HIFU.

58 In spite of the benefits of HIFU, a number of limitations have been reported, which

59 In the characterization of HIFU fields, the effect of nonlinear propagation is cons

60 o evaluate thermal and nonthermal effects of HIFU in cardiac ablation.

61 al mechanisms responsible for the failure of HIFU ablation in cardiac tissues.

62 o review HIFU to explain the fundamentals of HIFU, evaluate the evidence concerning the role of HIFU

63 Results show the potential of HIFU-mediated hyperthermia for enhanced delivery of poly

64 the release profile by varying the power of HIFU, the duration of exposure to HIFU, or both.

65 vely measuring the peak positive pressure of HIFU fields.

66 ine fibroid therapy, to evaluate the role of HIFU in the therapy of leiomyomas as well as to review t

67 evaluate the evidence concerning the role of HIFU in the treatment of prostate cancer (PC), review th

68 Clinical research on HIFU therapy for leiomyomas began in the 1990s, and the

69 Clinical research on HIFU therapy for localized PC began in the 1990s, and th

70 In current gynecologic oncology, HIFU is used clinically in the treatment of leiomyomas.

71 In current urological oncology, HIFU is used clinically in the treatment of PC.

72 When exposed to direct heating or HIFU, the PCM will melt and escape from the interiors of

73 PC), review the technologies used to perform HIFU and the published clinical literature regarding the

74 Patients with lower pre-HIFU PSA level and favourable pathologic Gleason score s

75 es based on a rabbit model and a preclinical HIFU system.

76 Tumors in the control group, pulsed HIFU and control group, and 1.0 mg/kg of bortezomib alon

77 However, pulsed HIFU and 1.0 mg/kg bortezomib increased the time to end

78 itional ablative HIFU, nondestructive pulsed HIFU (pHIFU) is present in the majority of novel applica

79 each group, half of the mice received pulsed HIFU exposure to their tumors immediately prior to each

80 Treatment of tumors with pulsed HIFU lowered the threshold level for efficacy of bortezo

81 The ability of pulsed-HIFU (1 M Hz, spatial averaged temporal peak intensity=2

82 netration and therapeutic efficacy of pulsed-HIFU exposures combined with (90)Y labeled B3 mAb in an

83 beled with cytotoxic radioisotopes or pulsed-HIFU exposure in addition to a combined therapy of (90)Y

84 This study demonstrates that pulsed-HIFU significantly enhances the delivery of (111)In-MX-B

85 The pulsed-HIFU exposures did not affect the vascular parameters in

86 ed high intensity focused ultrasound (pulsed-HIFU) has previously been shown to increase the accumula

87 al, following various treatments with pulsed-HIFU and/or (90)Y-B3.

88 Pretreatment with pulsed-HIFU significantly improved (p-value<0.05) survival over

89 ved (p-value<0.05) when combined with pulsed-HIFU, only in the tumor periphery.

90 o the solid tumors when combined with pulsed-HIFU.

91 A tumor on one flank was treated with pulsed-HIFU; the other tumor was used as an untreated control.

92 f other treatment regimens, such as repeated HIFU exposures for greater delivery enhancement of antib

93 This study intended to review HIFU in uterine fibroid therapy, to evaluate the role of

94 This study intended to review HIFU to explain the fundamentals of HIFU, evaluate the e

95 y suggest that short duration and sequential HIFU treatment could have significant benefits and that

96 The present strategy, HIFU-TiO2-SCX-LC-MS/MS, is the fastest analytical method

97 The HIFU effect on enhancing tumor uptake was greater at ear

98 The HIFU effect on enhancing tumor uptake was substantiated

99 The HIFU exposure shortened the peak tumor uptake time (24 v

100 Within 10 min after the HIFU exposure, the mice received intravenous (111)In-MX-

101 ology and safety will undoubtedly expand the HIFU role in this indication as more of patient series a

102 For the HIFU group, mild hyperthermia (40-42 degrees C) was comp

103 on tumor, and 3) determine the impact of the HIFU/nanobubble combination on intratumoral drug distrib

104 on tumor, and 3) determine the impact of the HIFU/nanobubble combination on intratumoral drug distrib

105 sibility of a recently developed approach to HIFU-induced ultrasound-guided tissue fractionation in a

106 e power of HIFU, the duration of exposure to HIFU, or both.

107 matory factors will be secreted secondary to HIFU activation, which is in the vicinity of the enginee

108 ted using high intensity focused ultrasound (HIFU) and microbubbles (MBs) can improve tumor drug deli

109 High-intensity focused ultrasound (HIFU) applies high-intensity focused ultrasound energy t

110 ng pulsed high-intensity focused ultrasound (HIFU) as an adjunctive pretreatment to bortezomib, a pro

111 ovided by high-intensity focused ultrasound (HIFU) combined with an inverse strategy based on TiO2 se

112 veness of high-intensity focused ultrasound (HIFU) combined with transarterial chemoembolization (TAC

113 if pulsed high-intensity focused ultrasound (HIFU) exposures could enhance tumor uptake of (111)In-MX

114 High intensity focused ultrasound (HIFU) has been introduced for treatment of cardiac arrhy

115 High-intensity focused ultrasound (HIFU) is a highly precise medical procedure used locally

116 ng-guided high-intensity focused ultrasound (HIFU) is a safe, effective, and durable treatment option

117 High Intensity Focused Ultrasound (HIFU) is an emerging noninvasive, nonionizing physical e

118 al use of high intensity focused ultrasound (HIFU) therapy for noninvasive tissue ablation has been r

119 ting with high-intensity focused ultrasound (HIFU) under MRI guidance to remotely permeabilize BBB.

120 fector by high-intensity focused ultrasound (HIFU).

121 -invasive high intensity focused ultrasound (HIFU).

122 Uterine fibroid treatment using HIFU was effective and safe in treating symptomatic uter

123 Adverse events associated with HIFU were evaluated.